The effect of Diltiazem gel and Lidocaine gel on the pain of rectosigmoidoscopy

The effect of Diltiazem gel in camparison with Lidocaine gel on the pain parameter in rectosigmoidoscopy without sedation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161205031252N6

Enrollment

Registered

2018-05-26

Start date

2018-05-22

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal bleeding. Gastrointestinal hemorrhage, unspecified

Interventions

Intervention 1: Intervention group: Diltiazem gel, 2cc, once, 5 minutes before rectosigmoidoscopy, rectal injection. Intervention 2: Control group: Lidocaine gel, 2cc, once, 5 minutes before rectosigm

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age 18 to 40 years Need to rectosigmoidoscopy Would like to participate in the study

Exclusion criteria

Exclusion criteria: Anal fissure Need general anesthesia

Design outcomes

Primary

Measure	Time frame
Pain scale. Timepoint: ?During rectosigmoidoscopy. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Hormati

Ghoum University of Medical Sciences

Hormatia@muq.ac.ir+98 25 3612 2053

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026